Article
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma.
Diagnostic pathology - 14 Oct 2020
Lee Hong Kyu, Kwon Mi Jung, Ra Yong Joon, Lee Hee Sung, Kim Hyoung Soo, Nam Eun Sook, Cho Seong Jin, Park Hye-Rim, Min Soo Kee, Seo Jinwon, Choe Ji-Young, Min Kyueng-Whan, Kang So Young
Abstract excerpt
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) still remains intractable disease with few therapeutic options. Programmed death-ligand 1 (PD-L1), which is essential for immune evasion, is involved in the pathogenesis of ESCC and thus is a potential therapeutic target. PIK3CA, KRAS, and BRAF mutations, microsatellite instability (MSI) caused by deficient mismatch repair (dMMR), and human papillomavirus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
